Diamyd Logo
This website is only intended for investors

Fighting diabetes

Diamyd Medical is a diabetes company active in the field of pharmaceutical development. The Company is headquartered in Stockholm, Sweden and shares are listed on NASDAQ OMX First North (ticker: DMYD B).
Our work is as important as ever. There is still no treatment that intervenes in the process that causes type 1 diabetes
Diabetes is associated with serious complications due to elevated and fluctuating blood sugar levels, causing substantial suffering and extensive costs for society.
During the past fiscal year, a new exciting chapter started for Diamyd Medical and our shareholders. We shall now go on to exploit the assets which have been built up in the Company over many years and...
Diamyd® is a GAD-based therapy under development for the treatment and prevention of autoimmune diabetes such as type 1 diabetes and LADA. Treatment with Diamyd® aims to intervene in the autoimmune...
rss icon
    
pdf icon
13 november 2013, 12:47
Årsredovisning 12/13